FDA Seeks Comment On Guidance For Clinical Trial Sponsors

By Cassie M. Chew · February 12, 2024, 5:11 PM EST

The U.S. Food and Drug Administration is set to publish draft guidance on Tuesday that aims to help clinical trial sponsors determine when they need to bring in a group of data...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Guidance

Recent Articles By Cassie

February 15, 2024
House Committee Blasts VA, Oracle For E-Record Failures
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
February 11, 2024
Rise In Billing For Catheters May Signal $2B Medicare Fraud
February 07, 2024
Existing Laws May Stymie AI Potential To Improve Healthcare
February 06, 2024
Proposed Rules in NY Target Anti-Competitive PBM Practices
February 05, 2024
Proposed Class Action Settlement May Cost Acella $46.5M
February 01, 2024
DOJ Looking For Privacy Perils In Digital Healthcare
January 31, 2024
FDA Has More Cyber Guidance Planned For Device Makers
January 29, 2024
HHS Urges Court To Reject Novo Nordisk Drug Plan Challenge
January 26, 2024
COVID-19 Immunity Law Shields Hospital From Negligence